Crossmark

Communicating with patients with nAMD and their families during the COVID-19 pandemic

Published Online: 2020-04-22

Published Print: 2020-06

Authors

,

Korobelnik, Jean-François

Loewenstein, Anat
Funding

Funding for this research was provided by:

Bayer Consumer Care AG, Switzerland (N/A)
License Information

Text and Data Mining valid from 2020-04-22

Version of Record valid from 2020-04-22
More Information

Article History

Received: 6 April 2020

Revised: 6 April 2020

Accepted: 9 April 2020

First Online: 22 April 2020

Document is current